GlobeNewswire

ThreeD Capital Announces Its Artificial Intelligence Investment, GoldSpot Discoveries, Reports Major Milestone At Sprott Mining Majority Owned Jerritt Canyon Project

Dela

TORONTO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- ThreeD Capital Inc. ("ThreeD" or the "Company") (CSE:IDK) an emerging Merchant Bank, led by Sheldon Inwentash, that focuses on investments in best of breed, early stage disruptive companies, is pleased to announce the achievement of a major milestone by its' artificial intelligence holding, Goldspot Discoveries Inc. ("Goldspot").  ThreeD owns a 22% equity interest (on a non-diluted basis) in Goldspot.

GOLDSPOT BRINGS ARTIFICIAL INTELLIGENCE TO MINERAL EXPLORATION

Goldspot has developed a machine-learning algorithm capable of significantly improving mineral exploration targeting. The Goldspot Algorithm is proven to mitigate investment risk and increase the efficiency and success rate of exploration in data-rich environments.  Goldspot was a finalist in the 2017 #DisruptMining Competition and took 2nd place at the 2016 Integra Gold Rush Challenge.

JERRITT CANYON PROJECT - USING ARTIFICIAL INTELLIGENCE TO IDENTIFY THE MOST PROSPECTIVE TARGETS

The Jerritt Canyon project, majority owned by Sprott Mining Inc., through Jerritt Canyon Gold LLC ("Jerritt"), a private mid-tier gold producer in Northern Nevada,  has hosted a historical resource of 12Moz Au with over 9Moz of past production.  Jerritt asked Goldspot to assess a significant amount of data in order to assist with continued exploration.

Goldspot consolidated over 30 years of historical remote sensing, mining, and exploration data into one comprehensive and functional geological model. Goldspot Artificial Intelligence was then able to use this geological model to identify correlations in the data layers of existing and historically mined deposits.

As a result, Goldspot was able to identify target zones with the highest prospectivity potential. The caliber of the newly identified target zones resulted in Goldspot being asked to layout a preliminary drill testing program on the best targets.

Jamie Lavigne, VP Exploration from the Jerritt Canyon mine-site stated "Goldspot has produced a very high-quality 3D geological model of the Jerritt Canyon district which provides an excellent foundation for continued exploration.  We look forward to drilling the priority targets derived by Goldspot through their detailed assessment (AI techniques) of the data.  The management of Jerritt Canyon Gold looks forward to future collaboration with Goldspot in the continued exploration and development of the Jerritt Canyon district."

ARTIFICAL INTELLIGENCE CREATES 5,000 METER DRILL PROGRAM

Denis Laviolette, CEO of Goldspot stated, "We are confident that our targets will unveil new, untapped zones to add to Jerritt's rich history. It is with great anticipation that we now move to the last phase of proof-of-concept, whereby Jerritt has agreed to commence the first 1,000-meters of a 5,000-meter drill program as soon as logistically possible."

Sheldon Inwentash, Chairman and CEO of ThreeD stated, "I want to thank Denis and the Goldspot team.  They have been working deeply to attain this level of acceptance of their analysis.  We at ThreeD feel this new and disruptive area of Artificial Intelligence will revolutionize the approach toward mineral discovery."

About ThreeD

ThreeD Capital, led by Sheldon Inwentash, primarily invests in best of breed, disruptive companies and leading technologies. We are industry agnostic, though the nature of our focus tends to attract companies in the high tech and bio tech space.  We have not abandoned our resources roots but have evolved them through the use of artificial intelligence to better identify, by several magnitudes, the exploration decision making process.

For further information: 
Gerry Feldman, CPA, CA
Chief Financial Officer and Corporate Secretary
feldman@threedcap.com
telephone: 416 606 7655 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ThreeD Capital Inc via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum